The Trials of Psychedelic Therapy
The Trials of Psychedelic Therapy

Author: Matthew Oram

Publisher: JHU Press

Published: 2018-10-01

Total Pages: 413

ISBN-13: 1421426218

DOWNLOAD EBOOK

The rise—and fall—of research into the therapeutic potential of LSD. After LSD arrived in the United States in 1949, the drug's therapeutic promise quickly captured the interests of psychiatrists. In the decade that followed, modern psychopharmacology was born and research into the drug's perceptual and psychological effects boomed. By the early 1960s, psychiatrists focused on a particularly promising treatment known as psychedelic therapy: a single, carefully guided, high-dose LSD session coupled with brief but intensive psychotherapy. Researchers reported an astounding 50 percent success rate in treating chronic alcoholism, as well as substantial improvement in patients suffering from a range of other disorders. Yet despite this success, LSD officially remained an experimental drug only. Research into its effects, psychological and otherwise, dwindled before coming to a close in the 1970s. In The Trials of Psychedelic Therapy, Matthew Oram traces the early promise and eventual demise of LSD psychotherapy in the United States. While the common perception is that LSD's prohibition terminated legitimate research, Oram draws on files from the Food and Drug Administration and the personal papers of LSD researchers to reveal that the most significant issue was not the drug's illegality, but the persistent question of its efficacy. The landmark Kefauver-Harris Drug Amendments of 1962 installed strict standards for efficacy evaluation, which LSD researchers struggled to meet due to the unorthodox nature of their treatment. Exploring the complex interactions between clinical science, regulation, and therapeutics in American medicine, The Trials of Psychedelic Therapy explains how an age of empirical research and limited government oversight gave way to sophisticated controlled clinical trials and complex federal regulations. Analyzing the debates around how to understand and evaluate treatment efficacy, this book will appeal to anyone with an interest in LSD and psychedelics, as well as mental health professionals, regulators, and scholars of the history of psychiatry, psychotherapy, drug regulation, and pharmaceutical research and development.

Psychedelic Drug Treatments
Psychedelic Drug Treatments

Author: Ben Sessa

Publisher: Mercury Learning and Information

Published: 2016-02-29

Total Pages: 229

ISBN-13: 193758559X

DOWNLOAD EBOOK

Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical compounds known as psychedelics affect the brain, provide you with the definitions of key terms particular to the neurological and psychological vocabulary, describe the specific disorders that can realistically be helped or relieved through treatment with psychedelics, and offer information with regard to current research being conducted in the field. This text will discuss the history of the earlier research efforts and will examine the likelihood of a resurgence of interest in the successful development of methods and practices of clinical therapy assisted by psychedelic drugs. The purpose of this volume is to promote an understanding of the use of psychedelics as tools to assist therapy and to challenge the 40-year-old prejudices against research into the possible benefits of these drugs. Features: •Questions and answers about the history, research, and treatments related to psychedelic drugs •Makes a case for the re-evaluation of psychedelics — LSD, MDMA (‘ecstasy’), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more — and their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches. •Includes numerous in-text resources such as links to Web sites, videos, articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical studies

Psychedelic Medicine
Psychedelic Medicine

Author: Richard Louis Miller

Publisher: Simon and Schuster

Published: 2017-11-21

Total Pages: 316

ISBN-13: 1620556987

DOWNLOAD EBOOK

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.

Psychedelic Psychotherapy
Psychedelic Psychotherapy

Author: R. Coleman

Publisher:

Published: 2017-09-15

Total Pages: 162

ISBN-13: 9780963009654

DOWNLOAD EBOOK

Psychedelic Psychotherapy contains valuable insiders' information for those using psychedelics for their own healing, and for practitioners who facilitate their sessions. Its focus is the nitty-gritty of healing trauma using MDMA, LSD, and psilocybin.

Psychedelic Humanities
Psychedelic Humanities

Author: Erika Dyck

Publisher: Frontiers Media SA

Published: 2024-06-19

Total Pages: 227

ISBN-13: 2832550487

DOWNLOAD EBOOK

Psychedelics are part of a resurgence of interest in consciousness studies, especially as altered states of consciousness are being re-examined in the context of psychedelic-assisted therapies. To date, discussions about psychedelics in modern medicine have been dominated by studies in biomedicine. However, given that cultural factors play a significant role in the subjective effects of psychedelics, psychedelics can be considered a uniquely powerful point of convergence between the cultural and biomedical. Writers and artists, alongside psychiatrists and pharmacologists, have participated in shaping ‘the psychedelic experience’ by drawing on a rich set of approaches that blend narrative, arts, and humanities concepts to explain and interpret psychedelic experiences and explore consciousness for creative purposes. Psychedelic studies, past and present, emphasize the importance of ‘set and setting’ or the context of psychedelic consumption and its paramount importance in shaping psychedelic experiences. These non-pharmacological factors rely on a different set of methods and interpretations that necessarily rely on studies conducted outside of the biomedical sciences.

The Psychedelic Renaissanc
The Psychedelic Renaissanc

Author: Ben Sessa

Publisher: Muswell Hill Press

Published: 2017-04

Total Pages: 250

ISBN-13: 9781908995254

DOWNLOAD EBOOK

Examines the mind-manifesting properties of psychedelic drugs and assesses the scientific evidence supporting their potential clinical and therapeutic use.

A Dose of Hope
A Dose of Hope

Author: Dan Engle

Publisher:

Published: 2021-07-02

Total Pages: 334

ISBN-13: 9781544521039

DOWNLOAD EBOOK

MDMA-assisted therapy for PTSD is in the final stages of FDA testing. Clinical trials are reporting a 70 percent cure rate for a condition that claims thousands of lives globally every day-hundreds in the US alone. But until it's fully legalized, MDMA is still a Schedule I drug, saddled with years of misunderstanding, misinformation, and misuse. In this groundbreaking, informative, and easy-to-read book, Dr. Dan Engle shows you the treatment through the eyes of a fictional patient so you can see how it works without ever setting foot in a doctor's office. Follow in-depth conversations between doctor and patient, learn about the history of MDMA-assisted therapy, understand how and why it helps, and experience the process for yourself-without ever having to take anything.  The treatment presented here is a synthesis of the real experiences and stunning results happening today in trials around the world. Whether you or a loved one suffer from PTSD, or you just want to heal something that's keeping you from living your best life, don't miss A Dose of Hope.